[Staphylococcal anatoxin, an alternative in the treatment of endogenous uveitis].
The paper presents one clinical study effected by fourty-four patients with endogenous uveitis which beneficiary of a general treatment with staphylococcal anatoxin. The conclusions of the study impose that one effective treatment is obtained at the young patients with anterior, acute uveitis with moderate inflammatory phenomenon and what present one effective answer of the lymphocyte T by interleukin 1. The application of the treatment suppose several exams reminiscent of the immunologic status especially of the cellular immunology.
Todea
V
V
Clinica Oftalmologică Cluj.
Crişan
M
M
Cristea
V
V
Pop
R
R
D000208:Acute Disease; D000293:Adolescent; D000328:Adult; D002648:Child; D005260:Female; D006801:Humans; D007111:Immunity, Cellular / Q000187:drug effects; D008297:Male; D008875:Middle Aged; D012008:Recurrence; D012189:Retrospective Studies; D013208:Staphylococcal Toxoid / Q000008:administration & dosage*; D013997:Time Factors; D014606:Uveitis, Anterior / Q000188:drug therapy* / Q000276:immunology
D013208:Staphylococcal Toxoid